Factors Underlying Reduced Hospitalizations for Myocardial Infarction During the COVID-19 Pandemic

Cardiac Arrest or Death

Changes in out-of-hospital cardiac arrest resuscitation quality during and after the COVID-19 pandemic

Resuscitation

Kennedy C, Nehme E, Anderson D, Dantanarayana A, Delardes B, Nehme Z

doi: 10.1016/j.resuscitation.2024.110419

Therapy and Intervention

Trends in Ischemic Stroke Hospitalization and Outcomes in the United States Pre- and Peri-COVID-19 Pandemic: A National Inpatient Sample Study

J Clin Med

Jafarli A, Di Napoli M, Kasper RS, Saver JL, McCullough LD, Salehi-Omran S, Mansouri B, Lioutas VA, Ismail M, Divani AA

doi: 10.3390/jcm14041354

Heart Failure

A nationwide, population-based study on specialized care for acute heart failure throughout the COVID-19 pandemic

Eur J Heart Fail

Cannata A, Mizani MA, Bromage DI, Piper SE, Hardman SMC, Sudlow C, de Belder M, Deanfield J, Gardner RS, Clark AL, Cleland JGF, McDonagh TA, on behalf of the CVD‐COVID‐UK/COVID‐IMPACT Consortium

doi: 10.1002/ejhf.3306

Heart, Artery and Coronary DiseasesMyocardial Infarction

Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID-19

J Am Heart Assoc

Patel S, Visotcky A, Devine A, Kode V, Kotlo S, Aljadah M, Sparapani R, Kulinski J

doi: 10.1161/JAHA.123.032572

Myocardial Infarction

Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden

J Am Coll Cardiol

Ni W, Stafoggia M, Zhang S, Ljungman P, Breitner S, Bont J, Jernberg T, Atar D, Agewall S, Schneider A

doi: 10.1016/j.jacc.2024.07.006

Heart, Artery and Coronary DiseasesFurther Publications

Impact of the COVID-19 pandemic on incidence of coronary heart disease in Bavaria, Germany: an analysis of health claims data

Heart

Schederecker F, Lehner CT, Eberl M, Schauberger G, Hansmann K, Donnachie E, Tauscher M, König A, Sundmacher L, Klug SJ

doi: 10.1136/heartjnl-2024-324181

Heart, Artery and Coronary Diseases

Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data

Eur J Heart Fail

Amir O, Elbaz-Greener G, Carasso S, Claggett B, Barbarash O, Zaman A, Christersson C, Kiatchoosakun S, Anonuevo J, Opolski G, Vaghaiwalla MF, van der Meer P, Zhou Y, Mann DL, Kober L, Steg G, Jering K, Kulac I, De Pasquale CG, McMurray JJV, Pfeffer MA, PARADISE‐MI Investigators and Committees

doi: 10.1002/ejhf.3542

Cardiovascular Risk and Diseases

Patterns of Telehealth Visits After the COVID-19 Pandemic Among Individuals With or at Risk for Cardiovascular Disease in the United States

J Am Heart Assoc

Bhatla A, Ding J, Mhaimeed O, Spaulding EM, Commodore-Mensah Y, Plante TB, Shan R, Marvel FA, Martin SS

doi: 10.1161/JAHA.124.036475

Myocardial Infarction

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

N Engl J Med

Yndigegn T, Lindahl B, Mars K, Alfredsson J, Benatar J, Brandin L, Erlinge D, Hallen O, Held C, Hjalmarsson P, Johansson P, Karlström P, Kellerth T, Marandi T, Ravn-Fischer A, Sundström J, Östlund O, Hofmann R, Jernberg T, REDUCE-AMI Investigators

doi: 10.1056/NEJMoa2401479

Related content